{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:41:08Z","timestamp":1742946068848,"version":"3.40.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,25]]},"DOI":"10.7759\/cureus.81185","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:37:53Z","timestamp":1742942273000},"source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy Rate Is High When the Length of the Luteal Phase During the In Vitro Fertilization Hormone Replacement Cycle Is 144 Hours or More Before Embryo Transfer"],"prefix":"10.7759","author":[{"given":"Eiji","family":"Nishio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiriko","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikari","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.03.011","article-title":"In\u00a0vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study","volume":"107","author":"Rubio C","year":"2017","unstructured":"Rubio C, Bellver J, Rodrigo L, et al.. In\u00a0vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertil Steril. 2017, 107:1122-9. 10.1016\/j.fertnstert.2017.03.011","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoab011","article-title":"Endometrial receptivity analysis (ERA): data versus opinions","volume":"2021","author":"Ruiz-Alonso M","year":"2021","unstructured":"Ruiz-Alonso M, Valbuena D, Gomez C, et al.. Endometrial receptivity analysis (ERA): data versus opinions. Hum Reprod Open. 2021, 2021:hoab011. 10.1093\/hropen\/hoab011","journal-title":"Hum Reprod Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2018.11.017","article-title":"Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction","volume":"38","author":"Griesinger G","year":"2019","unstructured":"Griesinger G, Tournaye H, Macklon N, et al.. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019, 38:249-59. 10.1016\/j.rbmo.2018.11.017","journal-title":"Reprod Biomed Online"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini P","year":"2014","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014, 10:261-75. 10.1038\/nrendo.2013.255","journal-title":"Nat Rev Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(65)90003-6","article-title":"Effect of dydrogesterone on hormone excretion in patients with dysmenorrhoea","volume":"1","author":"A4] Bell ET","year":"1965","unstructured":"A4] Bell ET, Loraine JA. Effect of dydrogesterone on hormone excretion in patients with dysmenorrhoea. Lancet. 1965, 1:403-6. 10.1016\/s0140-6736(65)90003-6","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1965.tb01416.x","article-title":"Duphaston in dysmenorrhoea; the results of a double blind clinical trial","volume":"72","author":"FA DV","year":"1965","unstructured":"FA DV. Duphaston in dysmenorrhoea; the results of a double blind clinical trial. J Obstet Gynaecol Br Commonw. 1965, 72:193-5. 10.1111\/j.1471-0528.1965.tb01416.x","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01302-z","article-title":"Role of dydrogesterone for luteal phase support in assisted reproduction","volume":"31","author":"Patki A","year":"2024","unstructured":"Patki A. Role of dydrogesterone for luteal phase support in assisted reproduction. Reprod Sci. 2024, 31:17-29. 10.1007\/s43032-023-01302-z","journal-title":"Reprod Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex023","article-title":"A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"Tournaye H","year":"2017","unstructured":"Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017, 32:1019-27. 10.1093\/humrep\/dex023","journal-title":"Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey306","article-title":"Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial","volume":"33","author":"Griesinger G","year":"2018","unstructured":"Griesinger G, Blockeel C, Sukhikh GT, et al.. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Hum Reprod. 2018, 33:2212-21. 10.1093\/humrep\/dey306","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1000980306","article-title":"A description of 34 human ova within the first 17 days of development","volume":"98","author":"HE AT","year":"1956","unstructured":"HE AT, RO J, AD EC. A description of 34 human ova within the first 17 days of development. Am J Anat. 1956, 98:435-93. 10.1002\/aja.1000980306","journal-title":"Am J Anat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)54069-2","article-title":"The window of embryo transfer and the efficiency of human conception in vitro","volume":"55","author":"Navot D","year":"1991","unstructured":"Navot D, Scott RT, Droesch K, et al.. The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril. 1991, 55:114-8. 10.1016\/s0015-0282(16)54069-2","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906103402304","article-title":"Time of implantation of the conceptus and loss of pregnancy","volume":"340","author":"Wilcox AJ","year":"1999","unstructured":"Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999, 340:1796-9. 10.1056\/NEJM199906103402304","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290227","article-title":"Uterine receptivity and the plasma membrane transformation","volume":"14","author":"Murphy CR","year":"2004","unstructured":"Murphy CR. Uterine receptivity and the plasma membrane transformation. Cell Res. 2004, 14:259-67. 10.1038\/sj.cr.7290227","journal-title":"Cell Res"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.4103\/0974-1208.165153","article-title":"Endometrial receptivity array: Clinical application","volume":"8","author":"Mahajan N","year":"2015","unstructured":"Mahajan N. Endometrial receptivity array: Clinical application. J Hum Reprod Sci. 2015, 8:121-9.","journal-title":"J Hum Reprod Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_74_18","article-title":"Personalized embryo transfer helps in improving in vitro fertilization\/ICSI outcomes in patients with recurrent implantation failure","volume":"12","author":"Patel JA","year":"2019","unstructured":"Patel JA, Patel AJ, Banker JM, et al.. Personalized embryo transfer helps in improving in vitro fertilization\/ICSI outcomes in patients with recurrent implantation failure. J Hum Reprod Sci. 2019, 12:59-66. 10.4103\/jhrs.JHRS_74_18","journal-title":"J Hum Reprod Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.05.004","article-title":"The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure","volume":"100","author":"Ruiz-Alonso M","year":"2013","unstructured":"Ruiz-Alonso M, Blesa D, D\u00edaz-Gimeno P, et al.. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013, 100:818-24. 10.1016\/j.fertnstert.2013.05.004","journal-title":"Fertil Steril"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1318376","article-title":"Vitrified-warmed blastocyst transfer on the 5th or 7th day of progesterone supplementation in an artificial cycle: a randomised controlled trial","volume":"33","author":"van de Vijver A","year":"2017","unstructured":"van de Vijver A, Drakopoulos P, Polyzos NP, et al.. Vitrified-warmed blastocyst transfer on the 5th or 7th day of progesterone supplementation in an artificial cycle: a randomised controlled trial. Gynecol Endocrinol. 2017, 33:783-6. 10.1080\/09513590.2017.1318376","journal-title":"Gynecol Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.03.017","article-title":"Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles","volume":"114","author":"Roelens C","year":"2020","unstructured":"Roelens C, Santos-Ribeiro S, Becu L, et al.. Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles. Fertil Steril. 2020, 114:125-32. 10.1016\/j.fertnstert.2020.03.017","journal-title":"Fertil Steril"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01322-7","article-title":"Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?","volume":"22","author":"Lorillon M","year":"2024","unstructured":"Lorillon M, Robin G, Keller L, et al.. Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?. Reprod Biol Endocrinol. 2024, 22:154. 10.1186\/s12958-024-01322-7","journal-title":"Reprod Biol Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12041","article-title":"Efficacy of the endometrial receptivity array for repeated implantation failure in Japan: A retrospective, two-centers study","volume":"16","author":"Hashimoto T","year":"2017","unstructured":"Hashimoto T, Koizumi M, Doshida M, et al.. Efficacy of the endometrial receptivity array for repeated implantation failure in Japan: A retrospective, two-centers study. Reprod Med Biol. 2017, 16:290-6. 10.1002\/rmb2.12041","journal-title":"Reprod Med Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.06.002","article-title":"A 5-year multicentre randomized controlled trial comparing personalized, frozen and fresh blastocyst transfer in IVF","volume":"41","author":"Sim\u00f3n C","year":"2020","unstructured":"Sim\u00f3n C, G\u00f3mez C, Cabanillas S, et al.. A 5-year multicentre randomized controlled trial comparing personalized, frozen and fresh blastocyst transfer in IVF. Reprod Biomed Online. 2020, 41:402-15. 10.1016\/j.rbmo.2020.06.002","journal-title":"Reprod Biomed Online"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-1112-2","article-title":"The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers","volume":"35","author":"Tan J","year":"2018","unstructured":"Tan J, Kan A, Hitkari J, et al.. The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers. J Assist Reprod Genet. 2018, 35:683-92. 10.1007\/s10815-017-1112-2","journal-title":"J Assist Reprod Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92955-w","article-title":"The precise determination of the window of implantation significantly improves ART outcomes","volume":"11","author":"Enciso M","year":"2021","unstructured":"Enciso M, Aizpurua J, Rodr\u00edguez-Estrada B, et al.. The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep. 2021, 11:13420. 10.1038\/s41598-021-92955-w","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040864","article-title":"Optimal duration of progesterone before cryopreserved embryo transfer in hormone replacement therapy cycles: A prospective pilot study","volume":"103","author":"Zhao L","year":"2024","unstructured":"Zhao L, Liu L, Dai Y, et al.. Optimal duration of progesterone before cryopreserved embryo transfer in hormone replacement therapy cycles: A prospective pilot study. Medicine (Baltimore). 2024, 103:e40864. 10.1097\/MD.0000000000040864","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/350150-pregnancy-rate-is-high-when-the-length-of-the-luteal-phase-during-the-in-vitro-fertilization-hormone-replacement-cycle-is-144-hours-or-more-before-embryo-transfer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:37:56Z","timestamp":1742942276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/350150-pregnancy-rate-is-high-when-the-length-of-the-luteal-phase-during-the-in-vitro-fertilization-hormone-replacement-cycle-is-144-hours-or-more-before-embryo-transfer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.81185","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}